Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
12	12	Search

2024	Biological functions and therapeutic potential of CKS2 in human cancer Frontiers in Oncology Yueliang Lai, Ye Lin
2023	RMI2 is a novel prognostic and predictive biomarker for breast cancer Cancer Medicine Lijie Zhang, Chuncheng Hao, Baojuan Han, Guangchun Zeng, Lili Han, Cong Cao, Hui Liu, Zhenbin Zhong, Xue Zhao, Jingxuan Wang, Qingyuan Zhang
2023	Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2 Open Life Sciences Zongren Wan, Jipeng Wang, Qing Liu, Dan Yang, Pengling Li, Lixin Wang
2022	Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I–III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity Cells Junkai Feng, Menglong Hu, Zongkuo Li, Guiming Hu, Yuting Han, Yan Zhang, Min Zhang, Jingli Ren
2022	RMI2 is a prognostic biomarker and promotes tumor growth in hepatocellular carcinoma Clinical and Experimental Medicine Yue Li, Xiaoqin He, Xiaoyu Zhang, Yangtao Xu, Wenliang Chen, Xin Liu, Ximing Xu
2022	Expression Profile and Molecular Basis of Cyclin-Dependent Kinases Regulatory Subunit 2 in Endometrial Carcinoma Detected by Diversified Methods Pathology and Oncology Research Li Gao, Gang Chen, Zi-Qian Liang, Jian-Di Li, Dong-Ming Li, Yu-Lu Tang, Deng Tang, Zhi-Guang Huang, Jun-Hong Chen, Jia-Yuan Luo, Jiang-Hui Zeng, Yi-Wu Dang, Zhen-Bo Feng
2022	Knockdown of replication protein A 3 induces protective autophagy and enhances cisplatin sensitivity in lung adenocarcinoma by inhibiting AKT/mTOR signaling via binding to cyclin‐dependent kinases regulatory subunit 2 Drug Development Research Lijun Chen, Ke Hu, Yu Liu, Lingli Liu, Juanjuan Tang, Xiaobing Qin
2022	Comprehensive Expression Profiling and Molecular Basis of CDC28 Protein Kinase Regulatory Subunit 2 in Cervical Cancer International Journal of Genomics Li Qin, Xiaoqiong Luo, Xiao Qin, Hongbao Huang, Lianling Zhang, Shengcai Chen, Xiaoqin Wu, Bingsheng Huang, Jian Pan, Jingxi Wei
2022	CKS2 Promotes the Growth in Non-Small-Cell Lung Cancer by Downregulating Cyclin-Dependent Kinase Inhibitor Pathobiology Zongren Wan, Lixin Wang, Dan Yang, Pengling Li, Qing Liu, Baolan Wang
2021	The Clinical Significance of RMI2 in Hepatocellular Carcinoma Technology in Cancer Research & Treatment Bin Zheng, MS, Heng Wang, MS, Jin-xue Wang, MS, Zheng-hong Liu, MS, Pu Zhang, MD, Dahong Zhang, MD
	Additional cited-by details will be shown when available from Crossref